Ard van Veelen

Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies

Amr Makady, Ard van Veelen, Páll Jónsson et al. · PharmacoEconomics · 2017 · 96 citations · Full text

Implementing managed entry agreements in practice: The Dutch reality check

Amr Makady, Ard van Veelen, Anthonius de Boer et al. · Health Policy · 2018 · 54 citations · Full text

Validation of an analytical method using HPLC–MS/MS to quantify osimertinib in human plasma and supplementary stability results

Ard van Veelen, Robin M.J.M. van Geel, Yvo de Beer et al. · Biomedical Chromatography · 2019 · 32 citations · Full text

Development and validation of an HPLC–MS/MS method to simultaneously quantify alectinib, crizotinib, erlotinib, gefitinib and osimertinib in human plasma samples, using one assay run

Ard van Veelen, Robin M.J.M. van Geel, Roy Schoufs et al. · Biomedical Chromatography · 2021 · 26 citations · Full text

Pharmacokinetic boosting of osimertinib with cobicistat in patients with non-small cell lung cancer: The OSIBOOST trial

Ard van Veelen, Judith L. Gulikers, Lizza Hendriks et al. · Lung Cancer · 2022 · 14 citations · Full text